3 results
Approved WMOCompleted
The primary objective of this study is to evaluate whether treatment with nesiritide improves patient outcomes (as measured by reduction in the composite of HF rehospitalization and all-cause mortality through 30 days after randomization [Day 30])…
Approved WMOCompleted
To determine the specificity of the effects of histamine H1-receptor blockade on different cognitive functions and processes.
Approved WMOPending
This study aims to evaluate IDRX-42 administered to participants with metastatic and/or surgically unresectable GIST.